Niagen Bioscience (NAGE) Finished Goods (2018 - 2019)
Niagen Bioscience's (NAGE) quarterly Finished Goods came in at $4.9 million in Q4 2019, up 99.06% year-on-year from $2.4 million in Q4 2018, and up 99.06% on a QoQ basis from $2.4 million in Q4 2018.
Niagen Bioscience (NAGE) Finished Goods (2018 - 2019) Analysis & Trends
Niagen Bioscience (NAGE) has 2 years of Finished Goods data on file, last reported at $4.9 million in Q4 2019.
- On a quarterly basis, Finished Goods rose 99.06% year-over-year to $4.9 million in Q4 2019; TTM through Dec 2019 was $4.9 million, a 99.06% increase from a year earlier, with the FY2019 full-year figure at $4.9 million, up 99.06% from the prior year.
- Finished Goods for Q4 2019 stood at $4.9 million, up from $2.4 million in the prior quarter.
- Over the last five years, Finished Goods for NAGE reached as high as $4.9 million in Q4 2019 and fell as low as $2.4 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 4.88 Mn |
| Dec 31, 2018 | 2.45 Mn |